Crossmark Global Holdings’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
3,936
+60
+2% +$15.8K 0.01% 606
2026
Q1
$1.03M Sell
3,876
-116
-3% -$31.4K 0.02% 594
2025
Q4
$1M Buy
3,992
+985
+33% +$262K 0.01% 603
2025
Q3
$863K Sell
3,007
-714
-19% -$191K 0.01% 679
2025
Q2
$977K Sell
3,721
-805
-18% -$196K 0.02% 625
2025
Q1
$1.05M Sell
4,526
-116
-2% -$28.1K 0.02% 592
2024
Q4
$1.06M Sell
4,642
-600
-11% -$138K 0.02% 573
2024
Q3
$1.17M Sell
5,242
-504
-9% -$111K 0.02% 557
2024
Q2
$1.17M Sell
5,746
-376
-6% -$76.5K 0.02% 546
2024
Q1
$1.34M Sell
6,122
-184
-3% -$40.5K 0.03% 521
2023
Q4
$1.43M Buy
6,306
+307
+5% +$64.5K 0.03% 495
2023
Q3
$1.22M Sell
5,999
-949
-14% -$200K 0.03% 523
2023
Q2
$1.28M Sell
6,948
-1,229
-15% -$238K 0.03% 523
2023
Q1
$1.61M Buy
8,177
+662
+9% +$136K 0.04% 462
2022
Q4
$1.52M Sell
7,515
-6,154
-45% -$1.2M 0.04% 462
2022
Q3
$2.4M Sell
13,669
-1,714
-11% -$351K 0.07% 306
2022
Q2
$3.1M Sell
15,383
-2,678
-15% -$571K 0.08% 273
2022
Q1
$4.09M Buy
18,061
+1,630
+10% +$383K 0.09% 238
2021
Q4
$4.43M Buy
16,431
+8,870
+117% +$2.2M 0.1% 222
2021
Q3
$1.83M Buy
7,561
+441
+6% +$111K 0.04% 412
2021
Q2
$1.69M Buy
7,120
+278
+4% +$63.3K 0.04% 440
2021
Q1
$1.5M Sell
6,842
-491
-7% -$98.5K 0.04% 459
2020
Q4
$1.28M Sell
7,333
-39
-0.5% -$6.74K 0.03% 499
2020
Q3
$1.19M Sell
7,372
-582
-7% -$92.2K 0.03% 482
2020
Q2
$1.14M Sell
7,954
-1,978
-20% -$274K 0.03% 495
2020
Q1
$1.08M Sell
9,932
-360
-3% -$51.9K 0.04% 445
2019
Q4
$1.5M Sell
10,292
-3,716
-27% -$536K 0.04% 450
2019
Q3
$2.02M Sell
14,008
-31
-0.2% -$4.52K 0.06% 354
2019
Q2
$2.08M Buy
14,039
+511
+4% +$71.3K 0.06% 376
2019
Q1
$1.78M Sell
13,528
-43
-0.3% -$5.3K 0.05% 410
2018
Q4
$1.47M Buy
13,571
+1,581
+13% +$212K 0.05% 434
2018
Q3
$1.79M Sell
11,990
-1,538
-11% -$234K 0.05% 435
2018
Q2
$2.09M Sell
13,528
-22
-0.2% -$3.32K 0.06% 381
2018
Q1
$1.88M Sell
13,550
-1,048
-7% -$154K 0.05% 429
2017
Q4
$2M Buy
14,598
+306
+2% +$40.4K 0.05% 429
2017
Q3
$1.85M Buy
+14,292
New +$1.91M 0.05% 436
2016
Q3
$1.85M Buy
+14,292
New +$1.68M 0.05% 436

Other funds holding LH

Crossmark Global Holdings's LH Position: Q2 2026 in Review

Crossmark Global Holdings increased its Labcorp (LH) stake by 1.5% in Q2 2026, buying an estimated $15.8K and bringing the position to 3,936 shares worth $1.1M. The position accounts for 0.01% of the portfolio, ranked #606.

Crossmark Global Holdings first reported a position in LH in Q3 2016 and has held it in 37 quarters since. The position peaked at $4.43M in Q4 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Crossmark Global Holdings held 3,936 shares of Labcorp worth $1.1M as of Q2 2026.
  • Crossmark Global Holdings bought 60 Labcorp shares in Q2 2026, an estimated $15.8K.
  • Labcorp made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #606 holding.
  • Crossmark Global Holdings first reported a position in Labcorp in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's Labcorp position peaked at $4.43M in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.